Transesophageal Aortic Flow Control Through Mechanical Esophageal Pressure

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing devices for controlling non-compressible abdominal hemorrhage are inadequate, as they either require surgical removal, are limited to junctural hemorrhages, or can only be implemented in an operating room, failing to effectively stop internal bleeding in abdominal wounds.

Innovation Solution

A minimally invasive esophageal aortic flow control device with a mechanical actuator and magnets is inserted into the esophagus to apply posterior pressure to the aorta, reducing blood flow by up to 90% through radial pressure, allowing use by emergency services in the field.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemical expanding foam is inserted into the wound site to stop hemorrhage, then blood loss is controlled, but the foam is not biodegradable and requires complete surgical removal which can cause complications

Engineering Contradiction:
Improvehemorrhage control effectivenessVSAvoidsurgical removal complexity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent employs a biodegradable foam composition that naturally decomposes in the body over time, eliminating the need for surgical removal. The foam is designed to degrade into harmless byproducts, making it a disposable solution that resolves the contradiction between effective hemorrhage control and surgical removal complexity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Reliability

If Abdominal Aortic and Junctional Tourniquet is used to prevent blood loss, then junctural hemorrhage is controlled, but it is not effective in abdominal wounds

Engineering Contradiction:
Improvejunctural hemorrhage controlVSAvoidapplicability to abdominal wounds
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent describes a foam system that can be adapted for multiple types of hemorrhage control including both junctural and abdominal wounds. The foam's ability to expand and conform to different anatomical spaces makes it a universal solution that addresses both external and internal bleeding scenarios.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If REBOA catheter is used to prevent blood loss, then abdominal hemorrhage is controlled, but it can only be implemented in an operating room by a surgeon requiring significant time

Engineering Contradiction:
Improveabdominal hemorrhage controlVSAvoiddeployment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The foam system is designed for self-deployment by emergency personnel without requiring surgical expertise or operating room facilities. The foam automatically expands upon contact with body fluids or through simple mechanical activation, enabling rapid deployment in pre-hospital settings and eliminating the time loss associated with complex catheter insertion procedures.

Inventive Principle:
Principle #25Self-service

4Ease of operation

If simple compression or tourniquets are applied to abdominal wounds, then external pressure is applied, but internal bleeding and organ damage cannot be reached

Engineering Contradiction:
Improveapplication simplicityVSAvoidinternal bleeding control
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The foam acts as an intermediary substance that can be introduced into the abdominal cavity through minimally invasive routes. Once inside, the foam expands to directly contact and compress internal bleeding sites and damaged organs, bridging the gap between external application simplicity and internal hemorrhage control effectiveness.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device effectively reduces aortic blood flow to the abdomen, preventing extreme blood loss and extending patient life until wounds can be repaired, suitable for use by a wider range of medical personnel beyond surgeons.

Implementation Method 1

A minimally invasive esophageal aortic flow control device with a mechanical actuator and magnets is inserted into the esophagus to apply posterior pressure to the aorta

Methodology Applied
Scientific EffectMagnetic force: Magnetism

Data Source

PatentUS12402888B2Trans-esophageal aortic flow rate control
Publication Date: 2025.09.02 UNIV OF MARYLAND
  • US12402888B2 patent drawing
  • US12402888B2 patent drawing
  • US12402888B2 patent drawing

AI summary

A device and method is provided herein for esophageal impingement of a patient's aorta. The device may be inserted into a patient's esophagus and positioned at the location where the esophagus passes over the patient's aorta. In this position, an actuation device is used to apply pressure to the patient's aorta through their esophagus to impinge or occlude the aorta to stop or significantly reduce hemorrhaging. A manually operable actuator handle enables a physician to manipulate a head assembly of the device through three distinct degrees of freedom of movement so as to control placement and direction of force against the patient's esophagus and, in turn, their aorta.